Clinical Trial Update: Adaptive Radiation Boost for Rectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating an adaptive radiation boost approach for rectal cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Rectum Cancer, Adenocarcinoma | Phase 1 | Status: RECRUITING